[Retracted] Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines

<div>Western blot results for C12-DMA lipoplexes. (A) Naked siRNA; (B) C12 : Chol (1 : 1) lipoplex; (C) C12 : DOTAP:Chol (1 : 1 : 1) lipoplex; (D) C12 : DOTAP (1 : 1) lipoplex; (E) lipofectamine 2000 + siRNA; (F) C12 : PEG (1 : 0.5) lipoplex. <i>β</i>-Actin was used as controls for the lipoplexes.</div>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: [Retracted] Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines 